StockWatch
·
Medical/Dental Instruments
Quarterly ResultAug 5, 2026, 04:22 PM

Envista Q2 Sales $731M, Adj. EPS $0.41; Raises FY26 Outlook

AI Summary

Envista Holdings Corporation announced strong financial results for the second quarter ended July 3, 2026, with sales reaching $731 million and adjusted diluted EPS increasing 58% year-over-year to $0.41. Both reporting segments, Specialty Products & Technologies and Equipment and Consumables, delivered positive core growth. Building on this performance, the company raised its full-year 2026 outlook for core sales growth, adjusted EBITDA, and adjusted EPS.

Key Highlights

  • Q2 2026 Sales were $731 million, with core sales growth of 5.0% YoY.
  • Q2 2026 Adjusted diluted EPS was $0.41, a 58% increase YoY.
  • Q2 2026 Adjusted EBITDA was $108 million, up 28% YoY, with a 14.7% margin.
  • Full-year 2026 core sales growth guidance raised to 3.5%-4.5% (from 2%-4%).
  • Full-year 2026 adjusted diluted EPS guidance raised to $1.50-$1.55 (from $1.35-$1.45).
  • Specialty Products & Technologies segment core growth was 3.1%.
  • Equipment and Consumables segment core growth was 8.5%.
  • Repurchased 2.4 million shares for approximately $59 million in Q2.